DMD c.1450G>T ;(p.E484*)

Variant ID: X-32632452-C-A

NM_004006.2(DMD):c.1450G>T;(p.E484*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.

Viruses
Ridgway, Harry H; Chasapis, Christos T CT; Kelaidonis, Konstantinos K; Ligielli, Irene I; Moore, Graham J GJ; Gadanec, Laura Kate LK; Zulli, Anthony A; Apostolopoulos, Vasso V; Mavromoustakos, Thomas T; Matsoukas, John M JM
Publication Date: 2022-05-11

Variant appearance in text: DMD: E484x
PubMed Link: 35632769
Variant Present in the following documents:
  • Main text
  • viruses-14-01029.pdf
View BVdb publication page



Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.

Cancer Gene Therapy
Denisova, Evgeniya E; Westphal, Dana D; Surowy, Harald M HM; Meier, Friedegund F; Hutter, Barbara B; Reifenberger, Julia J; Rütten, Arno A; Schulz, Alexander A; Sergon, Mildred M; Ziemer, Mirjana M; Brors, Benedikt B; Betz, Regina C RC; Redler, Silke S
Publication Date: 2022-06

Variant appearance in text: DMD: E484X
PubMed Link: 34045664
Variant Present in the following documents:
  • 41417_2021_347_MOESM4_ESM.xls, sheet 7
View BVdb publication page